title: The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity.
abstract: Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the leading cause of autosomal dominant Parkinson's disease (PD). LRRK2, a member of the ROCO protein family, contains both Ras GTPase-like (Roc) and kinase (MAPKKK) domains, as well as other functional motifs. Here, we have identified LRRK2 as the first mammalian ROCO protein that is an authentic and functional GTPase, defined by the ability to bind GTP and undergo intrinsic GTP hydrolysis. Furthermore, the Roc domain is sufficient for this native GTPase activity and binds and hydrolyzes GTP indistinguishably from the Ras-related small GTPase, Rac1. The PD-associated mutation, R1441C, located within the Roc domain, leads to an increase in LRRK2 kinase activity and a decrease in the rate of GTP hydrolysis, compared to the wild-type protein, in an in vitro assay. This finding suggests that the R1441C mutation may help stabilize an activated state of LRRK2. Additionally, LRRK2-mediated phosphorylation is stimulated upon binding of non-hydrolyzable GTP analogs, suggesting that LRRK2 is an MAPKKK-activated intramolecularly by its own GTPase. Since GTPases and MAPKKKs are upstream regulators of multiple signal transduction cascades, LRRK2 may play a central role in integrating pathways involved in neuronal cell signaling and the pathogenesis of PD.
authors: Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
authors: Luxuan
authors: L
authors: Guo
authors: Payal N
authors: PN
authors: Gandhi
authors: Wen
authors: W
authors: Wang
authors: Robert B
authors: RB
authors: Petersen
authors: Amy L
authors: AL
authors: Wilson-Delfosse
authors: Shu G
authors: SG
authors: Chen
mesh_terms: D002460:Cell Line; D004789:Enzyme Activation; D020558:GTP Phosphohydrolases / Q000378:metabolism*; D006160:Guanosine Triphosphate / Q000378:metabolism; D006801:Humans; D006868:Hydrolysis; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D008954:Models, Biological; D050505:Mutant Proteins / Q000378:metabolism; D009154:Mutation / Q000235:genetics; D010766:Phosphorylation; D017346:Protein Serine-Threonine Kinases / Q000737:chemistry / Q000378:metabolism*; D017434:Protein Structure, Tertiary
chemical_list: D050505:Mutant Proteins; D006160:Guanosine Triphosphate; C495280:LRRK2 protein, human; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D017346:Protein Serine-Threonine Kinases; D020558:GTP Phosphohydrolases
references: Gene. 1988 Jul 15;67(1):31-40
references: 3047011
references: Brain. 2005 Dec;128(Pt 12):3000-11
references: 16251215
references: Ann Neurol. 2006 Nov;60(5):617-8; author reply 618-9
references: 16847950
references: Arch Neurol. 2007 Mar;64(3):425-30
references: 17353388
references: Brain. 2005 Dec;128(Pt 12):2760-2
references: 16311269
references: Adv Neurol. 1999;80:153-9
references: 10410715
references: Eur J Hum Genet. 2006 Mar;14(3):322-31
references: 16333314
references: Cell Signal. 2003 May;15(5):463-9
references: 12639709
references: Trends Mol Med. 2006 Feb;12(2):76-82
references: 16406842
references: Biochem J. 2001 Oct 15;359(Pt 2):285-94
references: 11583574
references: Mol Neurodegener. 2006 Nov 30;1:17
references: 17137507
references: Semin Cell Dev Biol. 2001 Apr;12(2):193-9
references: 11292385
references: Int J Biochem Cell Biol. 2006;38(9):1469-75
references: 16600664
references: Science. 2002 Dec 6;298(5600):1912-34
references: 12471243
references: J Med Genet. 2005 Nov;42(11):e65
references: 16272257
references: Mol Cell Biol. 2001 Jul;21(14):4713-24
references: 11416147
references: Neurogenetics. 2005 Dec;6(4):171-7
references: 16172858
references: J Biol Chem. 1991 Nov 5;266(31):20840-8
references: 1939135
references: Am J Hum Genet. 2005 Apr;76(4):672-80
references: 15726496
references: Hum Mol Genet. 2007 Jan 15;16(2):223-32
references: 17200152
references: Annu Rev Neurosci. 2005;28:57-87
references: 16022590
references: Neurosci Lett. 2005 Dec 9;389(3):137-9
references: 16102903
references: Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18676-81
references: 16352719
references: Neurology. 2005 Sep 13;65(5):738-40
references: 16157908
references: Trends Biochem Sci. 2005 Mar;30(3):151-9
references: 15752987
references: Mov Disord. 2006 Jul;21(7):997-1001
references: 16602113
references: Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16842-7
references: 16269541
references: Nat Neurosci. 2006 Oct;9(10):1231-3
references: 16980962
references: Biochemistry. 2007 Feb 6;46(5):1380-8
references: 17260967
references: Annu Rev Biochem. 2005;74:29-52
references: 15952880
references: Neurology. 2005 Sep 13;65(5):741-4
references: 16157909
references: Acta Biochim Pol. 2001;48(4):829-50
references: 11995995
references: Ann Neurol. 2006 Nov;60(5):557-69
references: 17120249
references: Physiol Rev. 2001 Jan;81(1):153-208
references: 11152757
references: Neuron. 2004 Nov 18;44(4):601-7
references: 15541309
references: Neurobiol Dis. 2006 Aug;23(2):329-41
references: 16750377
references: Brain. 2005 Dec;128(Pt 12):2786-96
references: 16272164
references: Biochim Biophys Acta. 2003 Dec 7;1643(1-3):5-10
references: 14654223
references: Hum Mol Genet. 2006 Jan 15;15(2):223-32
references: 16321986
references: Neuron. 2004 Nov 18;44(4):595-600
references: 15541308